The analysis of Kras copy number indicates the ratio between the HPNE/KrasG12V and HPNE cells is about 4 times (Fig. 1a), which is consistent with the recent finding that mutant Kras copy gains are positively selected during tumour progression in KPC lung cancer mouse model20, 21. Here, KRAS is linked to neoplasm.